Day: 29. May 2018

Chugai Pharmaceutical announced that the humanized anti-human IL-6 receptor monoclonal antibody Actemra® for intravenous infusion 80 mg, 200 mg, 400 mg” : Tocilizumab (genetic recombination)] (hereinafter referred to as Actemra) was approved by the MHLW for an additional indication for “cytokine release syndrome associated with chimeric antigen receptor gene-introduced T cell infusion therapy”. This application […]

The company manufactures non-standard peptides for pharmaceutical use as APIs and will operate a factory with a floor area of over 10,000 m2 in the Settsu factory of Shionogi & Co., which is also a shareholder, from autumn of 2019. An R & D laboratory will also be established, and 20 to 30 technicians will […]

Cell Technology Co. has built a dental pulp cell bank. Sekisui has entered into a capital and business alliance with Cell Technology on joint research and development of dental pulp cells targeting periodontal diseases. Nikkei Biotech news release, May 29, 2018